Applied Genetic Technologies Corporation
AGTC · NASDAQ
6/30/2022 | 6/30/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$68,943 | -$57,829 | -$45,892 | -$2,006 |
| Dep. & Amort. | $1,512 | $1,460 | $1,335 | $1,273 |
| Deferred Tax | $0 | -$2,171 | $0 | $0 |
| Stock-Based Comp. | $3,457 | $2,678 | $2,998 | $4,029 |
| Change in WC | -$3,184 | $3,859 | $2,085 | -$25,640 |
| Other Non-Cash | $1,410 | $830 | -$2,146 | -$1,113 |
| Operating Cash Flow | -$65,748 | -$51,173 | -$41,620 | -$23,457 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,014 | -$1,861 | -$1,197 | -$311 |
| Net Acquisitions | $0 | $404 | -$4,000 | $148 |
| Inv. Purchases | $0 | -$20,992 | -$58,904 | -$74,781 |
| Inv. Sales/Matur. | $2,000 | $61,000 | $72,500 | $94,119 |
| Other Inv. Act. | $0 | -$404 | $0 | -$148 |
| Investing Cash Flow | -$14 | $38,147 | $8,399 | $19,027 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,207 | $69,261 | $34,811 | $36 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $7,076 | $79,615 | $44,981 | $68 |
| Financing Cash Flow | $7,076 | $79,615 | $44,981 | $68 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$58,686 | $66,589 | $11,760 | -$4,362 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $105,052 | $38,463 | $26,703 | $31,065 |
| End Cash | $46,366 | $105,052 | $38,463 | $26,703 |
| Free Cash Flow | -$67,762 | -$53,034 | -$42,817 | -$23,768 |